- Home
- BOLD vs ZCMD Comparison
BOLD vs ZCMD Comparison
Compare BOLD & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLD
- ZCMD
- Stock Information
- Founded
- BOLD 2018
- ZCMD 2012
- Country
- BOLD United States
- ZCMD China
- Employees
- BOLD N/A
- ZCMD N/A
- Industry
- BOLD
- ZCMD Other Consumer Services
- Sector
- BOLD
- ZCMD Real Estate
- Exchange
- BOLD Nasdaq
- ZCMD Nasdaq
- Market Cap
- BOLD 24.4M
- ZCMD 28.5M
- IPO Year
- BOLD 2024
- ZCMD 2020
- Fundamental
- Price
- BOLD $1.18
- ZCMD $1.10
- Analyst Decision
- BOLD Buy
- ZCMD
- Analyst Count
- BOLD 3
- ZCMD 0
- Target Price
- BOLD $4.00
- ZCMD N/A
- AVG Volume (30 Days)
- BOLD 276.3K
- ZCMD 241.3K
- Earning Date
- BOLD 08-11-2025
- ZCMD 01-01-0001
- Dividend Yield
- BOLD N/A
- ZCMD N/A
- EPS Growth
- BOLD N/A
- ZCMD N/A
- EPS
- BOLD N/A
- ZCMD N/A
- Revenue
- BOLD N/A
- ZCMD $15,864,773.00
- Revenue This Year
- BOLD N/A
- ZCMD N/A
- Revenue Next Year
- BOLD N/A
- ZCMD N/A
- P/E Ratio
- BOLD N/A
- ZCMD N/A
- Revenue Growth
- BOLD N/A
- ZCMD N/A
- 52 Week Low
- BOLD $1.00
- ZCMD $0.95
- 52 Week High
- BOLD $4.72
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- BOLD N/A
- ZCMD 47.03
- Support Level
- BOLD N/A
- ZCMD $1.10
- Resistance Level
- BOLD N/A
- ZCMD $1.24
- Average True Range (ATR)
- BOLD 0.00
- ZCMD 0.08
- MACD
- BOLD 0.00
- ZCMD -0.01
- Stochastic Oscillator
- BOLD 0.00
- ZCMD 14.93
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.